| Literature DB >> 27096874 |
J V Rau1, M Fosca2, V Graziani3, A A Egorov4, Yu V Zobkov5, A Yu Fedotov6, M Ortenzi7, R Caminiti8, A E Baranchikov9, V S Komlev10.
Abstract
Calcium phosphate bone cements (CPCs) with antibacterial properties are demanded for clinical applications. In this study, we demonstrated the use of a relatively simple processing route based on preparation of silver-doped CPCs (CPCs-Ag) through the preparation of solid dispersed active powder phase. Real-time monitoring of structural transformations and kinetics of several CPCs-Ag formulations (Ag = 0 wt %, 0.6 wt % and 1.0 wt %) was performed by the Energy Dispersive X-ray Diffraction technique. The partial conversion of β-tricalcium phosphate (TCP) phase into the dicalcium phosphate dihydrate (DCPD) took place in all the investigated cement systems. In the pristine cement powders, Ag in its metallic form was found, whereas for CPC-Ag 0.6 wt % and CPC-Ag 1.0 wt % cements, CaAg(PO₃)₃ was detected and Ag (met.) was no longer present. The CPC-Ag 0 wt % cement exhibited a compressive strength of 6.5 ± 1.0 MPa, whereas for the doped cements (CPC-Ag 0.6 wt % and CPC-Ag 1.0 wt %) the reduced values of the compressive strength 4.0 ± 1.0 and 1.5 ± 1.0 MPa, respectively, were detected. Silver-ion release from CPC-Ag 0.6 wt % and CPC-Ag 1.0 wt % cements, measured by the Atomic Emission Spectroscopy, corresponds to the average values of 25 µg/L and 43 µg/L, respectively, rising a plateau after 15 days. The results of the antibacterial test proved the inhibitory effect towards pathogenic Escherichia coli for both CPC-Ag 0.6 wt % and CPC-Ag 1.0 wt % cements, better performances being observed for the cement with a higher Ag-content.Entities:
Keywords: CaAg(PO3)3; bone cement; bone graft; calcium phosphate; infection; silver; tricalcium phosphate
Year: 2016 PMID: 27096874 PMCID: PMC4932467 DOI: 10.3390/jfb7020010
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Figure 1EDXRD spectra of pristine powder samples: CPC-Ag 0 wt % (control), CPC-Ag 0.6 wt %, and CPC-Ag 1.0 wt %.
Figure 2(a) Comparison between the first (after 1 min) and the last (after 50 h) diffraction pattern obtained upon CPC-Ag 0 wt % (control) cement; (b) 3D map of diffraction patterns collected to follow CPC-Ag 0 wt % (control) cement hardening process.
Figure 3Diffracted DCPD (041) Bragg reflection intensity versus time (CPC-Ag 0 wt % cement system).
Figure 4(a) Comparison between the first (after 1 min) and the last (after 40 h) diffraction pattern obtained upon CPC-Ag 0.6 wt % cement; (b) 3D map of diffraction patterns collected to follow CPC-Ag 0.6 wt % cement hardening process.
Figure 5(a) Comparison between the first (after 1 min) and the last (after 70 h) diffraction pattern obtained upon CPC-Ag 1.0 wt % cement; (b) 3D map of diffraction patterns collected to follow CPC-Ag 1.0 wt % cement hardening process.
Figure 6SEM images of (a) CPC-Ag 0 wt %; (b) CPC-Ag 0.6 wt % and (c) CPC-Ag 1.0 wt % cements after 24 h of hardening.
Figure 7Compressive strength of the investigated cements at 24 h after the end of mixing.
Figure 8Silver-ion release from cement samples into TRIS-HCl buffer solution during 30 days of immersion (CPC-Ag 0.6 wt % (1) and CPC-Ag 1.0 wt % (2)).
Figure 9Inhibition zones for Escherichia coli at 48 h: disks are numbered according to their Ag+ content in CPCs specimens.
Diameter of inhibition zones at 24 h and 48 h.
| Incubation Period, h | Average Diameter of Inhibition Zone, mm | ||
|---|---|---|---|
| CPC-Ag 0 wt % | CPC-Ag 0.6 wt % | CPC-Ag 1.0 wt % | |
| 24 | 0 | 1.10 ± 0.13 | 4.90 ± 0.17 |
| 48 | 0 | 2.40 ± 0.10 | 5.70 ± 0.21 |